{
    "@xmlns:dc": "http://purl.org/dc/elements/1.1/",
    "dc:title": "A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler",
    "dc:creator": [
        "BENSCH, George",
        "LAPIDUS, Robert J",
        "LEVINE, Bernard E",
        "LUMRY, William",
        "YEGEN, Omit",
        "KISELEV, Pavel",
        "DELLA CIOPPA, Giovanni"
    ],
    "dc:contributor": [
        "American College of Allergy, Asthma & Immunology (Funder/Sponsor)",
        "American College of Allergy, Asthma & Immunology. Annual meeting (Seattle 2000-11-03)"
    ],
    "dc:relation": [
        "Annals of allergy, asthma, & immunology -- Ann. allergy asthma immunol, ISSN 1081-1206, Vol. 86 (1) , pp. 19-27",
        "American College of Allergy, Asthma & Immunology. Annual meeting"
    ],
    "dc:date": "2001",
    "dc:type": [
        "Text",
        "Conference Paper"
    ],
    "dc:language": "English",
    "dc:publisher": "American College of Allergy, Asthma, & Immunology",
    "dc:format": [
        "print",
        "24 ref"
    ],
    "dc:subject": [
        {
            "@xml:lang": "fr",
            "#text": "Appareil respiratoire pathologie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Bronchopneumopathie obstructive"
        },
        {
            "@xml:lang": "fr",
            "#text": "Immunopathologie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Agoniste"
        },
        {
            "@xml:lang": "fr",
            "#text": "Allergie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Antiasthmatique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Asthme"
        },
        {
            "@xml:lang": "fr",
            "#text": "Aérosol"
        },
        {
            "@xml:lang": "fr",
            "#text": "Bronchodilatateur"
        },
        {
            "@xml:lang": "fr",
            "#text": "Chimiothérapie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Efficacité traitement"
        },
        {
            "@xml:lang": "fr",
            "#text": "Etude comparative"
        },
        {
            "@xml:lang": "fr",
            "#text": "Etude double insu"
        },
        {
            "@xml:lang": "fr",
            "#text": "Formotérol"
        },
        {
            "@xml:lang": "fr",
            "#text": "Homme"
        },
        {
            "@xml:lang": "fr",
            "#text": "Inhalation"
        },
        {
            "@xml:lang": "fr",
            "#text": "Randomisation"
        },
        {
            "@xml:lang": "fr",
            "#text": "Récepteur β2-adrénergique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Stimulant β-adrénergique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Traitement"
        },
        {
            "@xml:lang": "en",
            "#text": "Respiratory disease"
        },
        {
            "@xml:lang": "en",
            "#text": "Obstructive pulmonary disease"
        },
        {
            "@xml:lang": "en",
            "#text": "Immunopathology"
        },
        {
            "@xml:lang": "en",
            "#text": "Agonist"
        },
        {
            "@xml:lang": "en",
            "#text": "Allergy"
        },
        {
            "@xml:lang": "en",
            "#text": "Antiasthma agent"
        },
        {
            "@xml:lang": "en",
            "#text": "Asthma"
        },
        {
            "@xml:lang": "en",
            "#text": "Aerosols"
        },
        {
            "@xml:lang": "en",
            "#text": "Bronchodilator"
        },
        {
            "@xml:lang": "en",
            "#text": "Chemotherapy"
        },
        {
            "@xml:lang": "en",
            "#text": "Treatment efficiency"
        },
        {
            "@xml:lang": "en",
            "#text": "Comparative study"
        },
        {
            "@xml:lang": "en",
            "#text": "Double blind study"
        },
        {
            "@xml:lang": "en",
            "#text": "Formoterol"
        },
        {
            "@xml:lang": "en",
            "#text": "Human"
        },
        {
            "@xml:lang": "en",
            "#text": "Inhalation"
        },
        {
            "@xml:lang": "en",
            "#text": "Randomization"
        },
        {
            "@xml:lang": "en",
            "#text": "β2-Adrenergic receptor"
        },
        {
            "@xml:lang": "en",
            "#text": "β-Adrenergic receptor agonist"
        },
        {
            "@xml:lang": "en",
            "#text": "Treatment"
        },
        {
            "@xml:lang": "es",
            "#text": "Aparato respiratorio patología"
        },
        {
            "@xml:lang": "es",
            "#text": "Broncopneumopatía obstructiva"
        },
        {
            "@xml:lang": "es",
            "#text": "Inmunopatología"
        },
        {
            "@xml:lang": "es",
            "#text": "Agonista"
        },
        {
            "@xml:lang": "es",
            "#text": "Alergia"
        },
        {
            "@xml:lang": "es",
            "#text": "Agente antiasma"
        },
        {
            "@xml:lang": "es",
            "#text": "Asma"
        },
        {
            "@xml:lang": "es",
            "#text": "Aerosol"
        },
        {
            "@xml:lang": "es",
            "#text": "Broncodilatador"
        },
        {
            "@xml:lang": "es",
            "#text": "Quimioterapia"
        },
        {
            "@xml:lang": "es",
            "#text": "Eficacia tratamiento"
        },
        {
            "@xml:lang": "es",
            "#text": "Estudio comparativo"
        },
        {
            "@xml:lang": "es",
            "#text": "Estudio doble ciego"
        },
        {
            "@xml:lang": "es",
            "#text": "Formoterol"
        },
        {
            "@xml:lang": "es",
            "#text": "Hombre"
        },
        {
            "@xml:lang": "es",
            "#text": "Inhalación"
        },
        {
            "@xml:lang": "es",
            "#text": "Aleatorización"
        },
        {
            "@xml:lang": "es",
            "#text": "Receptor β2-adrenérgico"
        },
        {
            "@xml:lang": "es",
            "#text": "Estimulante β-adrenérgico"
        },
        {
            "@xml:lang": "es",
            "#text": "Tratamiento"
        },
        "002B02J: Histamine et antagonistes. Allergie / Histamine and antagonists. Allergy"
    ],
    "dc:rights": [
        "Inist-CNRS",
        "Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS"
    ],
    "dc:identifier": "Inist-CNRS record number 877853"
}